1-β-D-Arabinofuranosyluracil

We are 1-β-D-Arabinofuranosyluracil CAS:3083-77-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-β-D-Arabinofuranosyluracil
CAS.NO:3083-77-0
Synonyms:Uracil 1-β-D-Arabinofuranoside
1-β-D-Arabinofuranosyluracil
Uracil arabinoside
Spongouridine
1-((2R,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Molecular Formula:C9H12N2O6
Molecular Weight:244.20100
 
Physical and Chemical Properties:
Density:1.674
Melting point:220-222ºC
Index of Refraction:1.643
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥98.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.1%
Heavy metal:≤10ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of adenine arabinoside.

1-β-D-Arabinofuranosyluracil


Related News: The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.398489-26-4 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.L-Ornithine Monohydrochloride As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.3,4-Dihydro-7-(4-bromobutoxy)-2(1H)-quinolinone CAS:129722-34-5 In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.

Related Products
Product Name
4-(4-bromophenyl)dibenzofuran View Details
Methyl 2-amino-4-((2,5-dichlorophenyl)carbamoyl)benzoate View Details
5-Methyl-3-nitropicolinonitrile View Details
Benzotriazole-1-Carboxamidinium Tosylate manufacturer 8-iodo-1-octanol manufacturer trans-4-Methylcyclohexylamine hydrochloride manufacturer 4-Bromochlorobenzene manufacturer 3-chloro-2-(trifluoromethyl)aniline manufacturer